Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-12-10 pm EST 		5-day change 1st Jan Change
58.12 USD -1.00% Intraday chart for Bristol-Myers Squibb Company -0.97% +13.27%
Dec. 10 Agilent Cancer Diagnostic Assay Receives Certification to Comply with New EU Regulations MT
Dec. 10 Berenberg Raises Price Target on Bristol-Myers Squibb to $60 From $55, Keeps Hold Rating MT

Chart calendar Bristol-Myers Squibb Company

0cc88979286a22f014ec98cf8.-BG7B7R8AYPT_-EmSq_gDSJ0rndpTr9OvqBihbf0qos.kWbJdsIwYu3rs9RhFc2RbkpG8R8BBd0k3Mwx8YC6wuqcS-9d7Et52buQ2Q~10d35372b9424f1f5deb6c09db618c10

Upcoming events on Bristol-Myers Squibb Company

2025-02-06 06:59 am Q4 2024 Earnings Release
2025-02-06 08:00 am Q4 2024 Earnings Call
2025-04-24 06:59 am Q1 2025 Earnings Release
2025-04-24 08:00 am Q1 2025 Earnings Call
2025-07-31 06:59 am Q2 2025 Earnings Release
2025-07-31 08:00 am Q2 2025 Earnings Call
2025-10-30 06:59 am Q3 2025 Earnings Release
2025-10-30 08:00 am Q3 2025 Earnings Call
2026-01-28 Q4 2025 Earnings Release (Projected)
2026-04-22 Q1 2026 Earnings Release (Projected)
2026-07-22 Q2 2026 Earnings Release (Projected)
2026-10-28 Q3 2026 Earnings Release (Projected)

Past events on Bristol-Myers Squibb Company

2024-12-09 09:00 pm American Society of Hematology Meeting - Poster Presentation No:4142
2024-12-09 09:00 pm American Society of Hematology Meeting - Poster Presentation No:5055
2024-12-09 09:00 pm American Society of Hematology Meeting - Poster Presentation #4633
2024-12-09 09:00 pm American Society of Hematology Meeting - Poster Presentation #4387
2024-12-09 09:00 pm American Society of Hematology Meeting - Poster Presentation #3857
2024-12-09 08:30 pm American Society of Hematology Meeting - Oral Presentation No:1025
2024-12-09 08:00 pm American Society of Hematology Meeting - Oral Presentation #957
2024-12-09 07:30 pm American Society of Hematology Meeting - Oral Presentation #955
2024-12-09 06:45 pm American Society of Hematology Meeting - Oral Presentation #887
2024-12-09 06:45 pm American Society of Hematology Meeting - Oral Presentation #869
2024-12-09 06:30 pm American Society of Hematology Meeting - Oral Presentation No:922
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:3807
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:2628
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:3261
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation #3018
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:3382
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation #3028
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:3216
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation No:3476
2024-12-08 09:00 pm American Society of Hematology Meeting - Poster Presentation #3130

Past dividends on Bristol-Myers Squibb Company

2024-10-03 Quarterly 0.6 USD
2024-07-04 Quarterly 0.6 USD
2024-04-03 Quarterly 0.6 USD
2024-01-03 Quarterly 0.6 USD
2023-10-04 Quarterly 0.57 USD
2023-07-05 Quarterly 0.57 USD
2023-04-05 Quarterly 0.57 USD
2023-01-04 Quarterly 0.57 USD
2022-10-05 Quarterly 0.54 USD
2022-06-29 Quarterly 0.54 USD
2022-03-30 Quarterly 0.54 USD
2022-01-05 Quarterly 0.54 USD
2021-09-29 Quarterly 0.49 USD
2021-06-30 Quarterly 0.49 USD
2021-03-30 Quarterly 0.49 USD
2020-12-30 Quarterly 0.49 USD
2020-09-30 Quarterly 0.45 USD
2020-07-01 Quarterly 0.45 USD
2020-04-01 Quarterly 0.45 USD
2020-01-01 Quarterly 0.45 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		46 385
46 366
0.04%		46 159
45 911
0.54%		45 006
44 731
0.62%
47 463


46 871


44 212

EBITDA
Million USD		Released
Forecast
Spread 		20 493
21 878
-6.33%		20 123
20 368
-1.2%		17 498
18 255
-4.15%
5 460


18 212


15 881

EBIT
Million USD		Released
Forecast
Spread 		19 830
19 963
-0.67%		19 442
18 924
2.73%		16 785
16 921
-0.8%
4 706


17 168


15 566

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		8 098
7 644
5.94%		7 713
7 912
-2.51%		8 440
8 846
-4.59%
-6 919


8 205


7 170

Net income
Million USD		Released
Forecast
Spread 		6 994
6 219
12.46%		6 327
6 617
-4.39%		8 025
7 823
2.58%
-5 155


9 688


9 913

EPS
USD		Released
Forecast
Spread 		3,12
2,78
12.07%		2,95
2,97
-0.55%		3,86
3,73
3.53%
-2,72


5,17


5,18

Announcement Date04/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		11 337
11 498
-1.4%		11 226
11 811
-4.95%		10 966
10 959
0.06%		11 477
11 203
2.45%		11 865
11 451
3.62%		12 201
11 522
5.9%		11 892
11 246
5.75%
11 539


11 674


11 946


11 749


11 816

EBITDA
Million USD		Released
Forecast
Spread 		5 030
4 732
6.3%		4 268
6 031
-29.24%		4 539
5 339
-14.98%		3 816
4 833
-21.04%		-8 984
-8 394
-7.03%		7 477
4 280
74.7%		7 037
3 974
77.08%
4 038













EBIT
Million USD		Released
Forecast
Spread 		4 857
4 816
0.85%		4 251
4 785
-11.16%		4 360
4 206
3.66%		3 630
3 663
-0.91%		-8 329
-8 538
2.44%		4 881
4 023
21.32%		4 445
3 806
16.8%
3 720


4 473


4 516


4 522


3 643

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2 770
2 808
-1.34%		1 859
2 836
-34.44%		2 137
2 216
-3.58%		1 674
2 000
-16.28%		-11 516


1 286
1 175
9.45%		1 676
1 373
22.07%
1 278













Net income
Million USD		Released
Forecast
Spread 		2 262
2 290
-1.24%		2 073
2 165
-4.23%		1 928
1 585
21.63%		1 762
1 479
19.13%		-11 911
-10 359
-14.98%		1 680
1 110
51.33%		1 211
964
25.66%
1 735













EPS
USD		Released
Forecast
Spread 		1,07
1,19
-10.08%		0,99
1,16
-14.88%		0,93
0,89
4.03%		0,87
0,72
20.52%		-5,89
-4,84
-21.65%		0,83
0,68
21.8%		0,60
0,65
-7.93%
0,91


1,50


1,46


1,39


1,03

Announcement Date27/04/2327/07/2326/10/2302/02/2425/04/2426/07/2431/10/24-----

Upcoming sector events for Bristol-Myers Squibb Company

2025-01-08 HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release
2025-01-12 TILRAY BRANDS, INC.: Q2 2025 Earnings Release (Projected)
2025-01-20 AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 AARTI DRUGS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 ALEMBIC PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-21 JOHNSON & JOHNSON: Q4 2024 Earnings Release
2025-01-22 GLENMARK LIFE SCIENCES LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-27 GRANULES INDIA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28 MANKIND PHARMA LIMITED: Q3 2025 Earnings Release (Projected)
2025-01-28 TORRENT PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release (Projected)
More events

Past sector events for Bristol-Myers Squibb Company

2024-12-10 11:45 am MEDINCELL S.A.: Q2 2025 Earnings Release
2024-12-08 07:01 pm BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-12-04 02:06 am CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release
2024-11-28 DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release
2024-11-15 01:38 am BAVARIAN NORDIC A/S: Q3 2024 Earnings Release
2024-11-14 11:01 pm CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release
2024-11-14 09:03 am GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release
2024-11-14 07:00 am OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release
2024-11-14 02:49 am IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release
2024-11-14 01:30 am DERMAPHARM HOLDING SE: Q3 2024 Earnings Release

Quarterly revenue - Rate of surprise

quality-estimates-chart BRISTOL-MYERS-SQUIBB-COMP

Net sales - Rate of surprise

quality-estimates-chart BRISTOL-MYERS-SQUIBB-COMP

Annual profits - Rate of surprise

quality-estimates-chart BRISTOL-MYERS-SQUIBB-COMP
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Calendar Bristol-Myers Squibb Company